Functional Fluidics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 13

Functional Fluidics General Information

Description

Operator of a blood diagnostics unit intended to monitor red blood cell health objectively. The company's unit primarily offers a suite of proprietary blood function assays that are well validated and used to analyze red blood cells, providing contract research services to pharmaceutical, biotech, and academic research companies, enabling clients to improve patient care by accessing objective data on red blood cell health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 440 Burroughs Street
  • Suite 447
  • Detroit, MI 48202
  • United States
+1 (313)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 440 Burroughs Street
  • Suite 447
  • Detroit, MI 48202
  • United States
+1 (313)

Functional Fluidics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Functional Fluidics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 22-Nov-2024 Completed Generating Revenue
6. Later Stage VC 07-Dec-2023 Completed Generating Revenue
5. Later Stage VC 30-Dec-2022 Completed Generating Revenue
4. Grant 08-Oct-2022 Completed Generating Revenue
3. Seed Round 05-Jan-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Sep-2019 Completed Generating Revenue
1. Grant 17-Jun-2019 $25K Completed Generating Revenue
To view Functional Fluidics’s complete valuation and funding history, request access »

Functional Fluidics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 3
Seed 2
Seed 1 2,685,793 $0.000100 $0.64 $0.64 1x $0.64 16.78%
Seed 881,900 $0.000100 $0.06 $0.06 1x $0.06 5.51%
To view Functional Fluidics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Functional Fluidics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a blood diagnostics unit intended to monitor red blood cell health objectively. The company's unit primarily
Laboratory Services (Healthcare)
Detroit, MI
18 As of 2026

Austin, TX
 

Tel Aviv, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Functional Fluidics Competitors (4)

One of Functional Fluidics’s 4 competitors is Babson Diagnostics, a Venture Capital-Backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Babson Diagnostics Venture Capital-Backed Austin, TX
Sight Diagnostics Venture Capital-Backed Tel Aviv, Israel
PixCell Medical Technologies Formerly VC-backed Yokneam Ilit, Israel
Genalyte Venture Capital-Backed San Diego, CA
To view Functional Fluidics’s complete competitors history, request access »

Functional Fluidics Patents

Functional Fluidics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11933780-B2 System and method for assessing an effect on cellular units in an organism Active 17-Aug-2022
US-20240060958-A1 System and method for assessing an effect on cellular units in an organism Active 17-Aug-2022
US-11662353-B2 Method for assessing the effects of hypoxia on tissues Active 10-Sep-2020
US-20220074955-A1 Method for assessing the effects of hypoxia on tissues Active 10-Sep-2020
US-20230258662-A1 Method for assessing the effects of hypoxia on tissues Inactive 10-Sep-2020 G01N33/721
To view Functional Fluidics’s complete patent history, request access »

Functional Fluidics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Functional Fluidics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Community Transformation Fund Venture Capital Minority
Michigan Rise Venture Capital Minority
NYBC Ventures Corporate Venture Capital Minority
CB3 Holdings Venture Capital Minority
Ann Arbor SPARK Accelerator/Incubator Minority
You’re viewing 5 of 13 investors. Get the full list »

Functional Fluidics FAQs

  • When was Functional Fluidics founded?

    Functional Fluidics was founded in 2014.

  • Where is Functional Fluidics headquartered?

    Functional Fluidics is headquartered in Detroit, MI.

  • What is the size of Functional Fluidics?

    Functional Fluidics has 18 total employees.

  • What industry is Functional Fluidics in?

    Functional Fluidics’s primary industry is Laboratory Services (Healthcare).

  • Is Functional Fluidics a private or public company?

    Functional Fluidics is a Private company.

  • What is Functional Fluidics’s current revenue?

    The current revenue for Functional Fluidics is .

  • How much funding has Functional Fluidics raised over time?

    Functional Fluidics has raised $6.53M.

  • Who are Functional Fluidics’s investors?

    New Community Transformation Fund, Michigan Rise, NYBC Ventures, CB3 Holdings, and Ann Arbor SPARK are 5 of 13 investors who have invested in Functional Fluidics.

  • Who are Functional Fluidics’s competitors?

    Babson Diagnostics, Sight Diagnostics, PixCell Medical Technologies, and Genalyte are competitors of Functional Fluidics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process